← FDA Drug Approvals (Drugs@FDA)

SYNDROS

NDA · New Drug Application · Sponsor: WELLHOUSE PHARMA · Approved 2016-07-01

Drug application

FDA Application #

NDA205525

Application type

New Drug Application

Brand name

SYNDROS

Generic name

DRONABINOL

Active ingredients

DRONABINOL

Dosage form

SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

WELLHOUSE PHARMA

Manufacturer

Wellhouse Pharma, LLC

First approval

2016-07-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown